JPRN-UMIN000005196已完成4 期
Combination therapy trial of panitumumab(Pmab) with FOLFIRI for inoperable advanced recurrent colorectal cancer first-line chemotherapy - KPUMDS C-02 study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)A history of CPT-11 use 2)Contraindications to panitumumab 3)Contraindications to irinotecan 1.Severe bone marrow suppression 2.infection 3.Diarrhea 4.intestinal paralysis and intestinal obstruction 5.interstitial pneumonia, pulmonary fibrosis 6.Massive pleural or abdominal effusion 7. Icterus 8.Need to treatment with atazanavir sulfate 9.History of serious drug hypersensitivity " 4)Any other cases who are regarded as inadequate for study enrollment by the investigator.
研究者
相似试验
进行中（未招募）
不适用
A Phase II Clinical Trial of Panitumumab in Combination with Infusional Oxaliplatin and Oral Capecitabine (XELOX) Chemotherapy as 1st line Therapy in Patients with Colorectal Cancer and Advanced Liver Metastases - NDPreviously untreated Patients with Colorectal Cancer and Advanced Liver Metastases.MedDRA version: 9.1Level: LLTClassification code 10052358Term: Colorectal cancer metastaticEUCTR2007-002007-41-ITAZIENDA OSPEDALIERA ORDINE MAURIZIANO
进行中（未招募）
不适用
An Phase 2 Clinical Trial of Panitumumab in Conbination vith Irinotecan chemotherapy as 2nd line Therapy in subjects with Metastatic Colorectal Cancer.Ensayo Clínico fase II de Panitumumab combinado con quimioterapia de Irinotecan como tratamiento de segunda linea en sujetos con cáncer colorectal metastásico.EUCTR2006-006363-24-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)80
招募中
1 期
Phase1 trial of Panitumumab combined with S-1 and irrinotecan in advanced/metastatic colorectal cancerColorectal CancerJPRN-UMIN000004747Toho University, Ohashi Medical Center12
招募中
2 期
Multicenter phase II trial of panitumumab plus irinotecan and S-1 (PIRIS regimen) in patients treated by oxaliplatin-based chemotherapy with K-RAS wild-type advanced colorectal cancer.Colorectal CancerJPRN-UMIN000004574Showa University Nothern Yokohama Hospital48
尚未招募
2 期
Chemoradiation combined with panitumumab followed by surgery for patients with operable esophageal cancercancer of the esophagus10017991NL-OMON35643Academisch Medisch Centrum76